Programs & Pipeline

Activating RNA

Our technologies enable highly selective targeting and upregulation – or increased expression – of the vast majority of genes. RaNA is currently focused on developing treatments for a number of diseases, with lead programs in cystic fibrosis and ornithine transcarbamylase (OTC) deficiency, a urea cycle disorder.